Cystatin C is a disease-associated protein subject to multiple regulation

Immunology and Cell Biology

Volumn 93, Issue 5, 2015, Pages 442-451

  Xu, Yuekang ^a   Ding, Ying ^a   Li, Xinchen ^a   Wu, Xiaobing ^a  

^a ANHUI NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; CYTOKINE; GROWTH FACTOR; HORMONE; PROTEINASE; PROTEINASE INHIBITOR; BIOLOGICAL MARKER;

ARTICLE; ENZYME INHIBITION; HEMATOPOIETIC CELL; HUMAN; KIDNEY FUNCTION; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; ANIMAL; ATHEROSCLEROSIS; CELL LINEAGE; GENE EXPRESSION REGULATION; GENETICS; GLOMERULUS FILTRATION RATE; HEMATOPOIESIS; IMMUNOLOGY; INFECTION; KIDNEY FUNCTION TEST; METABOLISM; METASTASIS;

ANIMALS; ATHEROSCLEROSIS; BIOMARKERS; CELL LINEAGE; CYSTATIN C; GENE EXPRESSION REGULATION; GLOMERULAR FILTRATION RATE; HEMATOPOIESIS; HUMANS; INFECTION; KIDNEY FUNCTION TESTS; NEOPLASM METASTASIS;

EID: 84929943846     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2014.121     Document Type: Article

References (127)

1. Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, et al. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287-294
2. Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-a meta-analysis. Clin Biochem 2007; 40: 383-391
3. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-226
4. Shlipak MG, Mattes MD, Peralta CA. Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis 2013; 62: 595-603
5. Akerblom A, Eriksson N, Wallentin L, Siegbahn A, Barratt BJ, Becker RC, et al. Polymorphism of the cystatin C gene in patients with acute coronary syndromes: results from the PLATelet inhibition and patient Outcomes study. Am Heart J 2014; 168: 96-102 e2
6. O'Seaghdha CM, Tin A, Yang Q, Katz R, Liu Y, Harris T, et al. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality. Am J Kidney Dis 2014; 63: 16-22
7. Oc MA, Demir H, Cekmen MB, Isgoren S, Gorur GD, Bilgili U. Correlation of cystatin-C and radionuclidic measurement method of glomerular filtration rate in patients with lung cancer receiving cisplatin treatment. Ren Fail 2014; 36: 1043-1050
8. Laskin BL, Nehus E, Goebel J, Furth S, Davies SM, Jodele S. Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation. Biol Blood Marrow Transplant 2014; 20: 2056-2061
9. Knight EL, Verhave JC, Spiegelman D, Hillege HL, De Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421
10. Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem 2001; 47: 2055-2059
11. Kos J, Stabuc B, Cimerman N, Brunner N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 1998; 44: 2556-2557
12. Harman AN, Kraus M, Bye CR, Byth K, Turville SG, Tang O, et al. HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood 2009; 114: 85-94
13. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999; 104: 1191-1197
14. Kimura T, Jiang H, Konno T, Seto M, Iwanaga K, Tsujihata M, et al. Bunina bodies in motor and non-motor neurons revisited: a pathological study of an ALS patient after long-term survival on a respirator. Neuropathology 2014; 34: 392-397
15. Xu N, Zhang YY, Lin Y, Bao B, Zheng L, Shi GP, et al. Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: a histology study. Thromb Haemost 2014; 111: 333-344
16. Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, et al. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim Biophys Acta 2012; 1824: 68-88
17. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 2003; 197: 1323-1334
18. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000; 106: 1127-1137
19. Nishio C, Yoshida K, Nishiyama K, Hatanaka H, Yamada M. Involvement of cystatin C in oxidative stress-induced apoptosis of cultured rat CNS neurons. Brain Res 2000; 873: 252-262
20. Nagai A, Terashima M, Sheikh AM, Notsu Y, Shimode K, Yamaguchi S, et al. Involvement of cystatin C in pathophysiology of CNS diseases. Front Biosci 2008; 13: 3470-3479
21. Liang X, Nagai A, Terashima M, Sheikh AM, Shiota Y, Mitaki S, et al. Cystatin C induces apoptosis and tyrosine hydroxylase gene expression through JNK-dependent pathway in neuronal cells. Neurosci Lett 2011; 496: 100-105
22. Suzuki Y, Jin C, Yazawa I. Cystatin C triggers neuronal degeneration in a model of multiple system atrophy. Am J Pathol 2014; 184: 790-799
23. Nishiyama K, Konishi A, Nishio C, Araki-Yoshida K, Hatanaka H, Kojima M, et al. Expression of cystatin C prevents oxidative stress-induced death in PC12 cells. Brain Res Bull 2005; 67: 94-99
24. Kaur G, Mohan P, Pawlik M, DeRosa S, Fajiculay J, Che S, et al. Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy. Am J Pathol 2010; 177: 2256-2267
25. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998; 93: 1135-1145
26. Manoury B, Gregory WF, Maizels RM, Watts C. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol 2001; 11: 447-451
27. Kitamura H, Kamon H, Sawa S, Park SJ, Katunuma N, Ishihara K, et al. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity 2005; 23: 491-502
28. El-Sukkari D, Wilson NS, Hakansson K, Steptoe RJ, Grubb A, Shortman K, et al. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J Immunol 2003; 171: 5003-5011
29. Gresser O, Weber E, Hellwig A, Riese S, Regnier-Vigouroux A. Immunocompetent astrocytes and microglia display major differences in the processing of the invariant chain and in the expression of active cathepsin L and cathepsin S. Eur J Immunol 2001; 31: 1813-1824
30. Zavasnik-Bergant T, Repnik U, Schweiger A, Romih R, Jeras M, Turk V, et al. Differentiation-and maturation-dependent content, localization, and secretion of cystatin C in human dendritic cells. J Leukoc Biol 2005; 78: 122-134
31. Abrahamson M, Grubb A, Olafsson I, Lundwall A. Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett 1987; 216: 229-233
32. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 1359-1366
33. Jormsjo S, Wuttge DM, Sirsjo A, Whatling C, Hamsten A, Stemme S, et al. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2002; 161: 939-945
34. Sukhova GK, Wang B, Libby P, Pan JH, Zhang Y, Grubb A, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 2005; 96: 368-375
35. Bengtsson E, To F, Hakansson K, Grubb A, Branen L, Nilsson J, et al. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005; 25: 2151-2156
36. Eriksson P, Deguchi H, Samnegard A, Lundman P, Boquist S, Tornvall P, et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol 2004; 24: 551-557
37. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161-195
38. Huh CG, Hakansson K, Nathanson CM, Thorgeirsson UP, Jonsson N, Grubb A, et al. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol 1999; 52: 332-340
39. Kolwijck E, Kos J, Obermajer N, Span PN, Thomas CM, Massuger LF, et al. The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer. Eur J Clin Invest 2010; 40: 591-599
40. Kopitz C, Anton M, Gansbacher B, Kruger A. Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host. Cancer Res 2005; 65: 8608-8612
41. Wegiel B, Jiborn T, Abrahamson M, Helczynski L, Otterbein L, Persson JL, et al. Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways. PLoS ONE 2009; 4: e7953
42. Wallin H, Abrahamson M, Ekstrom U. Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes. J Biol Chem 2013; 288: 17019-17029
43. Turk B, Turk D, Salvesen GS. Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des 2002; 8: 1623-1637
44. Korant BD, Brzin J, Turk V. Cystatin, a protein inhibitor of cysteine proteases alters viral protein cleavages in infected human cells. Biochem Biophys Res Commun 1985; 127: 1072-1076
45. Bjorck L, Akesson P, Bohus M, Trojnar J, Abrahamson M, Olafsson I, et al. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 1989; 337: 385-386
46. Bjorck L, Grubb A, Kjellen L. Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol 1990; 64: 941-943
47. Collins AR, Grubb A. Inhibitory effects of recombinant human cystatin C on human coronaviruses. Antimicrob Agents Chemother 1991; 35: 2444-2446
48. Mottram JC, Brooks DR, Coombs GH. Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr Opin Microbiol 1998; 1: 455-460
49. Descoteaux A. Leishmania cysteine proteinases: virulence factors in quest of a function. Parasitol Today 1998; 14: 220-221
50. Das L, Datta N, Bandyopadhyay S, Das PK. Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol 2001; 166: 4020-4028
51. Sokol JP, Schiemann WP. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. Mol Cancer Res 2004; 2: 183-195
52. Sokol JP, Neil JR, Schiemann BJ, Schiemann WP. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta. Breast Cancer Res 2005; 7: R844-R853
53. Tian M, Schiemann WP. Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor beta in breast cancer. Transl Oncol 2009; 2: 174-183
54. Frendeus KH, Wallin H, Janciauskiene S, Abrahamson M. Macrophage responses to interferon-gamma are dependent on cystatin C levels. Int J Biochem Cell Biol 2009; 41: 2262-2269
55. Kumada T, Hasegawa A, Iwasaki Y, Baba H, Ikenaka K. Isolation of cystatin C via functional cloning of astrocyte differentiation factors. Dev Neurosci 2004; 26: 68-76
56. Hasegawa A, Naruse M, Hitoshi S, Iwasaki Y, Takebayashi H, Ikenaka K. Regulation of glial development by cystatin C. J Neurochem 2007; 100: 12-22
57. Hu Y, Hung AC, Cui H, Dawkins E, Bolos M, Foa L, et al. Role of cystatin C in amyloid precursor protein-induced proliferation of neural stem/progenitor cells. J Biol Chem 2013; 288: 18853-18862
58. Haan J, Maat-Schieman ML, Roos RA. Clinical aspects of cerebral amyloid angiopathy. Dementia 1994; 5: 210-213
59. Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, et al. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001; 8: 316-320
60. Ekiel I, Abrahamson M. Folding-related dimerization of human cystatin C. J Biol Chem 1996; 271: 1314-1321
61. Wahlbom M, Wang X, Lindstrom V, Carlemalm E, Jaskolski M, Grubb A. Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J Biol Chem 2007; 282: 18318-18326
62. Liu HL, Lin YM, Zhao JH, Hsieh MC, Lin HY, Huang CH, et al. Molecular dynamics simulations of human cystatin C and its L68Q varient to investigate the domain swapping mechanism. J Biomol Struct Dyn 2007; 25: 135-144
63. Abrahamson M, Grubb A. Increased body temperature accelerates aggregation of the Leu-68-4Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy. Proc Natl Acad Sci USA 1994; 91: 1416-1420
64. Abrahamson M, Jonsdottir S, Olafsson I, Jensson O, Grubb A. Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Human genetics 1992; 89: 377-380
65. Gudmundsson G, Hallgrimsson J, Jonasson TA, Bjarnason O. Hereditary cerebral haemorrhage with amyloidosis. Brain 1972; 95: 387-404
66. Olafsson I, Gudmundsson G, Abrahamson M, Jensson O, Grubb A. The amino terminal portion of cerebrospinal fluid cystatin C in hereditary cystatin C amyloid angiopathy is not truncated: direct sequence analysis from agarose gel electropherograms. Scand J Clin Lab Invest 1990; 50: 85-93
67. Asgeirsson B, Haebel S, Thorsteinsson L, Helgason E, Gudmundsson KO, Gudmundsson G, et al. Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-4Gln cystatin C variant in cerebrospinal fluids and monocyte cultures by MS. Biochem J 1998; 329: 497-503
68. Bjarnadottir M, Wulff BS, Sameni M, Sloane BF, Keppler D, Grubb A, et al. Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells. Mol Pathol 1998; 51: 317-326
69. Wei L, Berman Y, Castano EM, Cadene M, Beavis RC, Devi L, et al. Instability of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J Biol Chem 1998; 273: 11806-11814
70. Palsdottir A, Snorradottir AO, Thorsteinsson L. Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects. Brain Pathol 2006; 16: 55-59
71. Whelly S, Serobian G, Borchardt C, Powell J, Johnson S, Hakansson K, et al. Fertility defects in mice expressing the L68Q variant of human cystatin C: a role for amyloid in male infertility. J Biol Chem 2014; 289: 7718-7729
72. Pawlik M, Sastre M, Calero M, Mathews PM, Schmidt SD, Nixon RA, et al. Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid beta peptide. J Mol Neurosci 2004; 22: 13-18
73. Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, et al. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nat Genet 2007; 39: 1440-1442
74. Gauthier S, Kaur G, Mi W, Tizon B, Levy E. Protective mechanisms by cystatin C in neurodegenerative diseases. Front Biosci 2011; 3: 541-554
75. Selenica ML, Wang X, Ostergaard-Pedersen L, Westlind-Danielsson A, Grubb A. Cystatin C reduces the in vitro formation of soluble Abeta1-42 oligomers and protofibrils. Scand J Clin Lab Invest 2007; 67: 179-190
76. Sastre M, Calero M, Pawlik M, Mathews PM, Kumar A, Danilov V, et al. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol Aging 2004; 25: 1033-1043
77. Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, et al. Cystatin C modulates cerebral beta-amyloidosis. Nat Genet 2007; 39: 1437-1439
78. Tizon B, Ribe EM, Mi W, Troy CM, Levy E. Cystatin C protects neuronal cells from amyloid-beta-induced toxicity. J Alzheimers Dis 2010; 19: 885-894
79. Damme M, Suntio T, Saftig P, Eskelinen EL. Autophagy in neuronal cells: general principles and physiological and pathological functions. Acta Neuropathol (e-pub ahead of print 4 November 2014; doi: 10.1007/s00401-014-1361-4
80. Tizon B, Sahoo S, Yu H, Gauthier S, Kumar AR, Mohan P, et al. Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS ONE 2010; 5: e9819
81. Liu Y, Cai H, Wang Z, Li J, Wang K, Yu Z, et al. Induction of autophagy by cystatin C: a potential mechanism for prevention of cerebral vasospasm after experimental subarachnoid hemorrhage. Eur J Med Res 2013; 18: 21
82. Liu Y, Li J, Wang Z, Yu Z, Chen G. Attenuation of early brain injury and learning deficits following experimental subarachnoid hemorrhage secondary to cystatin C: possible involvement of the autophagy pathway. Mol Neurobiol 2014; 49: 1043-1054
83. Watanabe S, Hayakawa T, Wakasugi K, Yamanaka K. Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity. Cell Death Dis 2014; 5: e1497
84. Warfel AH, Zucker-Franklin D, Frangione B, Ghiso J. Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation. J Exp Med 1987; 166: 1912-1917
85. Rodriguez-Franco EJ, Cantres-Rosario YM, Plaud-Valentin M, Romeu R, Rodriguez Y, Skolasky R, et al. Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis. PLoS ONE 2012; 7: e36571
86. Xu Y, Schnorrer P, Proietto A, Kowalski G, Febbraio MA, Acha-Orbea H, et al. IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression. J Immunol 2011; 186: 3666-3673
87. Tsai CH, Yang SF, Huang FM, Chang YC. The upregulation of cystatin C in human gingival fibroblasts stimulated with cyclosporine A. J Periodontal Res 2009; 44: 459-464
88. Lee CW, Kim TH, Lee HM, Lee SH, Lee SH, Yoo JH, et al. Upregulation of elafin and cystatin C in the ethmoid sinus mucosa of patients with chronic sinusitis. Arch Otolaryngol Head Neck Surg 2009; 135: 771-775
89. Xu Y, Lindemann P, Vega-Ramos J, Zhang JG, Villadangos JA. Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system. J Biol Chem 2014; 289: 9730-9740
90. Kasabova M, Joulin-Giet A, Lecaille F, Gilmore BF, Marchand-Adam S, Saidi A, et al. Regulation of TGF-beta1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C. J Biol Chem 2014; 289: 16239-16251
91. Kotajima N, Yanagawa Y, Aoki T, Tsunekawa K, Morimura T, Ogiwara T, et al. Influence of thyroid hormones and transforming growth factor-beta1 on cystatin C concentrations. J Int Med Res 2010; 38: 1365-1373
92. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995; 55: 617-623
93. Yamawaki C, Takahashi M, Takara K, Kume M, Hirai M, Yasui H, et al. Effect of dexamethasone on extracellular secretion of cystatin C in cancer cell lines. Biomed Rep 2013; 1: 115-118
94. Palm DE, Knuckey NW, Primiano MJ, Spangenberger AG, Johanson CE. Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Res 1995; 691: 1-8
95. Hendriksen H, Datson NA, Ghijsen WE, van Vliet EA, da Silva FH, Gorter JA, et al. Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post-status epilepticus model. Eur J Neurosci 2001; 14: 1475-1484
96. Lukasiuk K, Pirttila TJ, Pitkanen A. Upregulation of cystatin C expression in the rat hippocampus during epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy. Epilepsia 2002; 43: 137-145
97. Aronica E, van Vliet EA, Hendriksen E, Troost D, Lopes da Silva FH, Gorter JA. Cystatin C, a cysteine protease inhibitor, is persistently up-regulated in neurons and glia in a rat model for mesial temporal lobe epilepsy. Eur J Neurosci 2001; 14: 1485-1491
98. Dutta G, Barber DS, Zhang P, Doperalski NJ, Liu B. Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity. J Neurochem 2012; 122: 752-763
99. Wu XJ, Dong ZQ, Lu QH. The role of cystatin C in vascular remodeling of ballooninjured abdominal aorta of rabbits. Mol Biol Rep 2014; 41: 6225-6231
100. Wang Z, Wu D, Vinters HV. Hypoxia and reoxygenation of brain microvascular smooth muscle cells in vitro: cellular responses and expression of cerebral amyloid angiopathyassociated proteins. APMIS 2002; 110: 423-434
101. Lee DC, Close FT, Goodman CB, Jackson IM, Wight-Mason C, Wells LM, et al. Enhanced cystatin C and lysosomal protease expression following 6-hydroxydopamine exposure. Neurotoxicology 2006; 27: 260-276
102. Singla DK, McDonald DE. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol Heart Circ Physiol 2007; 293: H1590-H1595
103. Xie L, Terrand J, Xu B, Tsaprailis G, Boyer J, Chen QM. Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation. Cardiovasc Res 2010; 87: 628-635
104. Huaux F, Lasfargues G, Lauwerys R, Lison D. Lung toxicity of hard metal particles and production of interleukin-1, tumor necrosis factor-alpha, fibronectin, and cystatin-c by lung phagocytes. Toxicol Appl Pharmacol 1995; 132: 53-62
105. Balbin M, Abrahamson M. PCR assay for a polymorphic DdeI site in the promoter region of the human cystatin C gene. Hum Genet 1992; 88: 710
106. Huh C, Nagle JW, Kozak CA, Abrahamson M, Karlsson S. Structural organization, expression and chromosomal mapping of the mouse cystatin-C-encoding gene (Cst3). Gene 1995; 152: 221-226
107. Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 2004; 117: 5965-5973
108. Loew M, Hoffmann MM, Koenig W, Brenner H, Rothenbacher D. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events. Arterioscler Thromb Vasc Biol 2005; 25: 1470-1474
109. Zhan Y, Vega-Ramos J, Carrington EM, Villadangos JA, Lew AM, Xu Y. The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells. Eur J Immunol 2012; 42: 2889-2900
110. Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, Fuchsberger M, et al. Cutting edge: generation of splenic CD8+ and CD8-dendritic cell equivalents in Fmslike tyrosine kinase 3 ligand bone marrow cultures. J Immunol 2005; 174: 6592-6597
111. Choi JH, Do Y, Cheong C, Koh H, Boscardin SB, Oh YS, et al. Identification of antigenpresenting dendritic cells in mouse aorta and cardiac valves. J Exp Med 2009; 206: 497-505
112. Choi JH, Cheong C, Dandamudi DB, Park CG, Rodriguez A, Mehandru S, et al. Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 2011; 35: 819-831
113. Tamura T, Thotakura P, Tanaka TS, Ko MS, Ozato K. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 2005; 106: 1938-1947
114. Laricchia-Robbio L, Tamura T, Karpova T, Sprague BL, McNally JG, Ozato K. Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages. Proc Natl Acad Sci USA 2005; 102: 14368-14373
115. Tsujimura H, Tamura T, Gongora C, Aliberti J, Reis e Sousa C, Sher A, et al. ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro. Blood 2003; 101: 961-969
116. Anderson KL, Perkin H, Surh CD, Venturini S, Maki RA, Torbett BE. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol 2000; 164: 1855-1861
117. Tsujimura H, Tamura T, Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol 2003; 170: 1131-1135
118. Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI, et al. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 1997; 173: 423-432
119. Ostner G, Lindstrom V, Hjort Christensen P, Kozak M, Abrahamson M, Grubb A. Stabilization, characterization, and selective removal of cystatin C amyloid oligomers. J Biol Chem 2013; 288: 16438-16450
120. Wasselius J, Johansson K, Hakansson K, Abrahamson M, Ehinger B. Cystatin C uptake in the eye. Graefes Arch Clin Exp Ophthalmol 2005; 243: 583-592
121. Kaseda R, Iino N, Hosojima M, Takeda T, Hosaka K, Kobayashi A, et al. Megalin-mediated endocytosis of cystatin C in proximal tubule cells. Biochem Biophys Res Commun 2007; 357: 1130-1134
122. Ekstrom U, Wallin H, Lorenzo J, Holmqvist B, Abrahamson M, Aviles FX. Internalization of cystatin C in human cell lines. FEBS J 2008; 275: 4571-4582
123. Wallin H, Bjarnadottir M, Vogel LK, Wasselius J, Ekstrom U, Abrahamson M. Cystatins-extra-and intracellular cysteine protease inhibitors: high-level secretion and uptake of cystatin C in human neuroblastoma cells. Biochimie 2010; 92: 1625-1634
124. Dean RA, Butler GS, Hamma-Kourbali Y, Delbe J, Brigstock DR, Courty J, et al. Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol Cell Biol 2007; 27: 8454-8465
125. Lenarcic B, Krasovec M, Ritonja A, Olafsson I, Turk V. Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett 1991; 280: 211-215
126. Laurent-Matha V, Huesgen PF, Masson O, Derocq D, Prebois C, Gary-Bobo M, et al. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. FASEB J 2012; 26: 5172-5181
127. Martino S, Tiribuzi R, Ciraci E, Makrypidi G, D'Angelo F, di Girolamo I, et al. Coordinated involvement of cathepsins S, D and cystatin C in the commitment of hematopoietic stem cells to dendritic cells. Int J Biochem Cell Biol 2011; 43: 775-783